We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PIRS market cap is 17.96M. The company's latest EPS is USD -18.5898 and P/E is -0.73.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 19.52M | 1.3M | 53k | 0 | 0 |
| Operating Income | 3.09M | -5.48M | -5.3M | -4.18M | -3.14M |
| Net Income | -10.75M | -4.58M | -4.89M | -3.59M | -2.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.28M | 29.32M | 31.42M | 25.9M | 42.81M |
| Operating Income | -27.16M | -33.92M | -51.83M | -43.47M | -15.84M |
| Net Income | -25.47M | -37.23M | -45.74M | -33.28M | -24.54M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.38M | 38.68M | 29.5M | 25.05M | 20.52M |
| Total Liabilities | 28.87M | 11.92M | 7.53M | 6.35M | 4.25M |
| Total Equity | 30.51M | 26.76M | 21.96M | 18.71M | 16.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 141.1M | 105.01M | 153.56M | 95.49M | 38.68M |
| Total Liabilities | 89.75M | 73.98M | 102.81M | 67.56M | 11.92M |
| Total Equity | 51.35M | 31.03M | 50.76M | 27.93M | 26.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.15M | -53.82M | -7M | -8.48M | -8.33M |
| Investing | 8.55M | 12M | 9M | 11.18M | 11.32M |
| Financing | 19.78M | 19.8M | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.47M | -45.9M | -7.66M | -59.93M | -53.82M |
| Investing | 9.84M | 39.21M | -949k | -21.24M | 12M |
| Financing | 32.17M | 10.12M | 59.13M | 7.21M | 19.8M |
| Market Cap | 17.96M |
| Price to Earnings Ratio | -0.73 |
| Price to Sales Ratio | 0.42 |
| Price to Cash Ratio | 1.03 |
| Price to Book Ratio | 0.67 |
| Dividend Yield | - |
| Shares Outstanding | 1.32M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -1.11% |
| 52 Week High | 22.32 |
| 52 Week Low | 6.20 |
| Spread (Intraday) | 6.56 (45.05%) |
| Company Name | Pieris Pharmaceuticals Inc |
| Address |
3773 howard hughes pkwy las vegas, nevada 89169 |
| Website | https://www.pieris.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
